Article
CYP1B1 gene polymorphism modifies pancreatic cancer risk but not survival.
Neoplasma - 1 Jan 2010
Vrana D, Novotny J, Holcatova I, Hlavata I, Soucek P
Abstract excerpt
UNLABELLED: Pancreatic cancer represents one of the biggest problems of current oncology. The risk factors of pancreatic cancer development, as well as factors affecting survival are poorly understood. Since biotransformation enzymes modify detoxification of carcinogens, we supposed, that arelationship between their polymorphism and the risk of pancreatic cancer development and eventually its clinical outcome may...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
